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Protective immunity in experimental malaria 
infections is dependent on CD4 T cells and 
B cells (1). However, the factors responsible 
for activation and regulation of these respo  nses
and the accompanying pathology (1) are 
poorly understood.
DCs provide a critical link between innate 
and adaptive immune responses (2). In addition 
to diff  erent populations such as conventional 
CD11c+CD8+ and CD8− DCs and plasma-
cytoid DCs (pDCs; reference 3), there are diff  er-
ences in how DCs are stimulated by pathogens 
(for review see reference 4). DC populations 
express distinct pattern recognition receptors 
such as Toll-like receptors (TLRs) and respond 
to diff  erent microbial products (5), resulting in 
diff  erent immune responses.
CD11c+ DCs are essential for the develop-
ment of immunity to liver stages of malaria (6), 
but their role in the immune response to blood 
stages is not known. Plasmodium chabaudi–in-
fected erythrocytes activate mouse BM-derived 
CD11c+ DCs in vitro (7), and Plasmodium fal-
ciparum has been shown to induce Flt-3 ligand-
induced BM DCs to produce IFN-α (8) and 
up-regulate CD86 (9). In P. chabaudi infections 
in mice, there is an increase in the number 
of CD11c+ DCs in the spleen (10), and the 
expression of CD80, CD86, and CD40 is up-
regulated (11, 12). However, P. falciparum– and 
P. yoelii–infected erythrocytes also suppress 
DC maturation and T cell responses (13, 14).
Blood-stage malaria infection stimulates a strong 
Th1 response that is down-regulated as the in-
fection progresses, resulting in a later Th re-
sponse that provides help for B cells (Fig. 1; 
reference 1). Because the T cell response is in-
fl  uenced by its interaction with DCs, it will be 
critical to determine those DCs that are able to 
present malaria antigens (Ags) in vivo.
In this study, we investigate the ability of 
two major subpopulations of splenic CD11c+ 
DC populations, CD8+ (CD11b−) and CD8− 
(CD11b+), to present malaria peptides and acti-
vate malaria-specifi  c transgenic (Tg) CD4 T cells 
during a P. chabaudi infection. We focus on the 
Ag MSP1 (Fig. S1, available at http:/ /www.
jem.org/cgi/content/full/jem.20052450/DC1),
which can stimulate protective immunity. 
CD8− DCs isolated at the infective peak pres-
ent more MSP1 peptide than CD8+ DCs. Al-
though both subsets of DCs can induce IFN-γ 
production, only CD8− DCs at this time in-
duced the proliferation of MSP1-specifi  c Tg 
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CD4 T cells and considerable IL-4 and IL-10. This suggests 
that the switch from a Th1 to Th2 response later in infec-
tion with P. chabaudi (Fig. 1; reference 1) can be attributed 
to the activation of CD4 T cells by a specifi  c subset of 
splenic DCs.
RESULTS AND DISCUSSION
Presentation of MSP1 T cell epitopes 
by CD8− and CD8+ DCs in vivo during infection
We investigated in vivo processing and presentation by 
splenic CD11c+CD8+ and CD8− DCs from P. chabaudi–in-
fected mice at diff  erent days after a primary infection. Both 
CD8+ and CD8− DC populations were activated in that 
CD40 and CD86 were rapidly up-regulated by day 5 (before 
peak infection; see Fig. 1) on both DC populations, whereas 
the level of MHC class II expression increased noticeably 
only on CD8+ DCs (Fig. S2, available at http://www.jem.
org/cgi/content/full/jem.20052450/DC1).
To determine their capacity to capture, process, and pre-
sent malaria Ags in vivo, isolated splenic DCs from mice at 
diff  erent stages of infection were compared for their ability to 
stimulate two MSP1-specifi  c T cell hybridomas ex vivo. The 
B5 hybridoma recognizes an epitope (MSP11,157–1,171 located 
within the p39 fragment of the MSP1 protein), and B7 rec-
ognizes MSP11,690–1,709 in the MSP121 fragment (Fig. S1; 
r  eference 15). MSP1 peptides were present on both populations 
of DCs between days 5 and 14 of infection, as shown by their 
ability to activate the hybridomas (Fig. 2, A and B). 
Although both CD11c+CD8+ and CD8− DCs from 
P. chabaudi–infected mice presented MSP1 peptides to both
hybridomas (Fig. 2), they did so with diff  erent effi   cacy and 
  kinetics. At the peak of infection (days 7–11), CD8− DCs were 
signifi   cantly more eff   ective than CD8+ DCs (P < 0.05 
for days 7–11; Fig. 2, A and B). The diff  erent presentation 
  capacity of the DC cannot be explained by MHC class II 
expression because CD11c+CD8+ expressed higher levels of 
class II than CD8− DCs (Fig. S2), and presented   synthetic 
peptide added to the culture with equal effi   ciency (Fig. 2 A 
and Fig. S3 C, available at http://www.jem.org/cgi/content/
full/jem.20052450/DC1).
Because the dose response of the hybridomas to their 
peptides is similar (15), a comparison can be made of the rela-
tive presentation of B7 and B5 peptides during the infection. 
The B7 peptide was presented earlier in infection and for 
longer than the B5 peptide. A small response to the B7 pep-
tide was observed at days 3 (not depicted) and 5 until day 14 
(Fig. 2, A and B), whereas B5 was only detected on DCs dur-
ing peak parasitaemia (days 7–11). This suggests that condi-
tions for uptake, processing, or presentation of the diff  erent 
parts of MSP1 may be diff  erent during infection. Phagocyto-
sis by DCs of the membrane-bound region of MSP1 contain-
ing the B7 peptide may be more eff  ective than uptake of the 
B5 peptide, which is located within one of the cleaved frag-
ments of MSP1 and may be more frequently endocytosed as 
soluble Ag. Alternatively, the fragment, which contains the 
B7 epitope, is more resistant to proteolysis than the B5 epi-
tope and may be retained longer in the processing compart-
ments, allowing a more eff   ective presentation of the B7 
epitope (16).
The diff  erence in presentation of MSP1 peptides be-
tween CD8+ and CD8− DCs were not intrinsic properties 
because CD8+ DCs isolated from uninfected mice were 
more eff  ective at presenting MSP1 peptides than CD8− 
DCs after coculture with schizonts (Fig. S3), suggesting 
that the malaria infection itself may have changed the rela-
tive Ag-presenting capacities of the two populations of 
CD11c+ DCs.
Both subsets of DCs induced IFN-𝗄 production 
in malaria-specifi  c TCR Tg T cells, but only CD8− DCs 
from infected mice induced proliferation 
and high levels of IL-4 and IL-10 production
The presence of MSP1 peptides on DCs from infected 
mice detected by T cell hybridomas gives no indication of 
the ability of DCs to induce CD4 T cell responses, such as 
proliferation and cytokine production. Therefore, we de-
termined whether the two CD11c+ splenic DC popula-
tions activated diff  erent T cell responses from CD4 T cells 
of Tg mice carrying a TCR specifi  c for the B5 epitope of 
MSP1 (17). When Tg CD4 T cells were cultured with 
CD8+ and CD8− DCs isolated from malaria-infected mice 
(7 d after infection), we found that only CD8− DCs in-
duced T cell proliferation (Fig. 3 A). CD8+ DCs failed to 
stimulate proliferation even in the presence of 1 μM of 
exogenously added B5 peptide (Fig. 3 B). Although CD8− 
DCs from infected mice induced a >10-fold increase in 
T cell numbers, the numbers of Tg T cells did not increase 
during 6 d of coculture with CD8+ DCs from infected 
mice (Fig. 3). Both DC subsets induced IFN-γ produc-
tion from the T cells, but only CD8− DCs led to the 
  development of IL-4 and IL-10 production in T cells. Im-
portantly, when cell recovery was taken into account, 
CD8− DCs induced considerably more of both IL-2 and 
IFN-γ (Fig. 3 A).
The more eff  ective stimulation of Tg T cells by CD8− 
DCs during infection is unlikely to be caused by intrinsic dif-
ferences in their potential to present peptide to Tg T cells, 
as the diff  erences were only apparent in DCs obtained from 
  infected mice; both naive CD8+ and CD8− DCs cocultured 
Figure 1.  Course of P. chabaudi infection showing changes in 
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with 1 μM of schizonts or peptide in vitro induced the pro-
liferation of Tg T cells (Fig. S4, available at http://www.jem.
org/cgi/content/full/jem.20052450/DC1). The culture of 
either DC subset with schizonts but not peptide led to IL-4 
production, possibly via additional signals to the DC pro-
vided by the infected RBC. However, naive CD8+ and 
CD8− DCs induced equivalent amounts of IL-10 in the pres-
ence of peptide.
The eff  ects seen in vivo were also unlikely to be caused 
by limiting peptide on CD8+ DCs because MHC class II ex-
pression on CD8+ DCs is greater than CD8− (Fig S2). Both 
infected CD8+ and CD8− DCs present to the B5 hybridoma 
(Fig. 2), and, most importantly, CD8+ DCs from infected 
mice pulsed with 1 μM of exogenous peptide were still 
  unable to induce proliferation in the Tg T cells and induced 
considerably less cytokine (Fig. 3 B).
Figure 2.  CD8− DCs present MSP1 peptides more effi  ciently than 
CD8+ DCs in vivo at peak parasitaemia. (A) CD11chigh DCs were en-
riched from spleens of mice at 5, 8, 11, and 14 d after infection with 105 
P. chabaudi, sorted into CD8+ (open squares) or CD8− DCs (closed circles), 
and cultured with 2 × 104 B5 or B7 hybridoma cells for 24 h. IL-2 produc-
tion was measured as described in Materials and methods. As a control for 
presentation capacity, the same number of DCs from infected mice were 
cultured in the presence of 1 μM of peptide (dotted lines). The data repre-
sent means and SEM (>10%; error bars) of triplicate samples. Statistical 
analysis was performed as described in Materials and methods. (B) The 
T cell hybridoma response to MSP1 peptides on splenic DCs from infected 
mice represented as a fraction of the maximal response to DCs that were 
pulsed with excess exogenous peptide. Sorted CD8+ (white bars) and CD8− 
(black bars) DCs were cultured, and IL-2 was measured as described in A. 
Responses shown (at 104 DCs) are the means of maximum responses to 
exogenously pulsed peptide with the SEM of triplicate samples. The data 
are from a representative experiment of three performed. *, P = 0.05–0.01; 
**, P = 0.01–0.001; and ***, P < 0.001 denote signifi  cant differences.1430  SPLENIC DENDRITIC CELLS AND MALARIA INFECTION | Sponaas et al.
Increase in splenic CD11c+CD8− DC numbers during infection
At the peak of infection, the spleen contains a large number 
of CD11c+ cells (Fig. S5, available at http://www.jem.org/
cgi/content/full/jem.20052450/DC1), which mostly com-
prise the CD8− subpopulation. The increase in the number 
of CD8− DCs was quantifi  ed by FACS analysis. During a 
P. chabaudi infection, there is a 20-fold increase in spleen cell 
numbers (18). In this study, we show a concomitant increase 
in the total number of CD11c+ DCs (Fig. 4 B), with the 
greatest increases observed in the CD8− populations (which 
includes the population presenting MSP1; Fig. 4, A and B). 
The majority of the CD8− DCs in the spleen during 
P. chabaudi infection expressed intermediate levels of CD11c 
(Fig. 4, A and B) and were distinct from pDCs, as >90% did 
not stain with the pDC-specifi  c antibody (Ab) 120G8 (not 
depicted; reference 19). However, they expressed CD11b, 
intermediate levels of GR-1 and F4/80, as well as MHC class 
II (unpublished data) similar to infl  ammatory DCs, which mi-
grate into the spleen in mice infected with Listeria monocytogenes 
(20). Lymphotoxin α1β2 produced in the spleen can induce 
the expansion of the CD8− DC subpopulation from splenic 
DC precursors (21), suggesting that in addition to the infl  ux 
of new DCs, the generation of CD8− DCs may take place in 
the spleen during infection.
Apoptosis is greater in CD8+ than in CD8− splenic DCs 
during infection
CD11c+CD8+ DCs have a shorter lifespan than CD8− DCs 
(22). This could infl  uence the ability of DCs to process and 
present Ags in vivo, with concomitant eff  ects on the subse-
quent T cell response. To address this, we assessed cell death 
in the CD11c+CD8+ and CD8− DC population during the 
course of infection using 7AAD as a marker of apoptosis 
(Fig. 4 C). The greatest increase in cell death was observed 
among CD8+ DCs; within 5 d of infection, >50% of the 
CD11c+CD8+ DCs were apoptotic. This number declined 
as parasite numbers decreased (day 20), suggesting that high 
parasitaemia was associated with the selective death of CD8+ 
DCs. In contrast, there was little increase in the number of 
apoptotic CD8− DCs. The 7AAD+ CD8+ DC also ex-
pressed Annexin V on the cell surface (Fig. 4 D). This indi-
cated that 7AAD staining was not caused by live CD8+ DCs 
endocytosing apoptotic cells. Therefore, it is possible that 
CD8+ DCs may have endocytosed Ags early in infection, 
undergone apoptosis, and been replaced by fresh DCs. Their 
inability to support proliferation or signifi  cant IL-4 (P < 
0.001) or IL-10 (P = 0.01–0.001) production of CD4 
Figure 3.  CD8− but not CD8+ DCs from infected mice induced 
proliferation and high levels of IL-4 and IL-10 production in spe-
cifi  c Tg CD4 T cells. (A) CD11c+CD8+ (open squares) and CD8− (closed 
circles) DCs from mice 7 d after infection with P. chabaudi (i) were cul-
tured in the presence of 105 Tg T cells for 3 d, and the proliferative re-
sponse was determined. CD8+ (white bars) and CD8− (black bars) splenic 
DCs from mice 7 d after inoculation with P. chabaudi (ii) were cultured in 
the presence of enriched CD4 B5 T cells. Graphs shown are the ELISAs of 
the mean values of a representative experiment (of three performed) with 
the SEM (error bars) of triplicate samples. Asterisks denote signifi  cant 
differences. (B) CD8+ DCs from infected mice cocultured with peptide 
induce signifi  cantly lower levels of IL-4 and IL-10 and fail to induce pro-
liferation in Tg T cells. Sorted DCs from infected mice were cultured in the 
presence of 1 μM B5 peptide and B5 T cells and tested for Ag-specifi  c 
proliferation (i) and cytokine production (ii) as in A.JEM VOL. 203, June 12, 2006  1431
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T cells may be the result of apoptosis taking place before 
providing the signals for the induction of T cell proliferation 
and cytokine production. Engagement of TLR signaling 
pathways such as MyD88 have been shown to lead to apop-
tosis (23), and products of malaria-infected RBCs such as 
haemozoin and glycosyl-phosphatidylinositol may act 
through TLR9 and TLR2 (9). It remains to be directly dem-
onstrated whether the engagement of these TLRs induces 
apoptosis in CD8+ DCs and, thus, the loss of stimulatory 
  eff  ects on T cells.
Interestingly, at day 14 after infection, the CD11c+CD8+ 
DC presented the B7 epitope and synthetic peptides better 
than the CD8− DC. This may indicate that at this stage of 
infection, the spleen has been repopulated with fresh CD8+ 
DCs or that the cytokine environment at this time does not 
induce apoptosis in CD8+ DCs.
The most striking fi  nding in our studies was that CD8− 
DCs were the only conventional DC population in the acute 
stage of infection able to drive MSP1-specifi  c Tg CD4 T cells 
into proliferation and production of high levels of IL-4 and IL-10. 
This is similar to observations in Leishmania-infected BALB/c 
mice in which CD8− DCs were also responsible for Th2 cyto-
kine induction (24). In this case, a nonprotective T cell response 
was observed. In malaria infection, however, it represents a 
change in the immune response, with time to allow both a pro-
tective Th1 response and B cell help from Th2 cytokines.
It has been previously proposed that diff  erent DC popu-
lations induce Th1 or Th2 cytokine production in T cells (25). 
Figure 4.  Increase in the numbers of CD11c+CD8− DCs in spleens 
during infection with P. chabaudi. BALB/c mice were infected with 105 
P. chabaudi, killed on different days after infection, and stained with anti-
CD11c and CD8 Abs. (A) Representative FACS plot of DCs from naive mice 
at day 9 and 20 after infection. Numbers in boxes refer to the percent-
ages of cells in each gate. (B) CD11c+CD8+ DCs (white bars) and 
CD11c+CD8− DCs (black bars) in spleens of naive mice and mice on days 
5, 6, 9, and 20 after infection; total number of CD11c+ cells (top), cells 
with intermediate levels of CD11c+ (middle), and cells with high surface 
expression of CD11c (bottom). Isotype controls on both cell populations 
showed no staining at any time during infection. The numbers represent 
the means and SEM (>10%; error bars) of three mice. (C) Splenic 
CD11c+CD8+ DCs are more apoptotic than CD8− DCs in spleens of mice 
infected with P. chabaudi. The number of 7AAD-positive CD11chigh CD8+ 
(white bars) and CD11chigh CD8− DCs (black bars) in spleens of naive mice 
and mice infected for days 5, 6, 9, and 20. The data are means and SEM 
(>10%) of three mice and are representative of three experiments. 
  Asterisks denote that the differences are signifi  cant. (D) Representative 
FACS plot of CD11c+CD8+ DCs stained with 7AAD and Annexin V from 
mice 9 d after infection.1432  SPLENIC DENDRITIC CELLS AND MALARIA INFECTION | Sponaas et al.
However, in our experiments, the capacity of DCs to acti-
vate and induce cytokines in T cells was associated with in-
fection and was not an intrinsic property.
An eff  ective Ag dose is a major factor infl  uencing T cell 
responses. DCs incubated with low doses of peptide favor 
a Th2 response, whereas high doses of Ag induce a Th1 
  response (5). Therefore, variations in MSP1 peptide expres-
sion on DC subsets may be important for the diff  erentiation 
of CD4 T cells. However, Ag dose in our case is unlikely to 
be the explanation, as the diff  erences in T cell activation and 
cytokine production in response to the two DC populations 
from infected mice were observed at peak parasitaemia, when 
Ag dose is high. The responses of the T cell hybridomas sug-
gested, in fact, that the amount of peptide was greater on 
CD8− DCs than CD8+ cells despite the fact that they in-
duced an IL-4 production in the Tg CD4 T cells. Further-
more, the addition of exogenous peptide to DCs from 
infected mice resulted in a greater IL-4 response of Tg T cells 
only with CD8− DCs (Fig. 3 B). These cytokine responses 
induced by CD11c+CD8− DCs are more in line with the 
idea that the changing environment in the spleen during in-
fection, the cytokine milieu, and the activation state of DCs 
are the major contributing factors. It has been found that Th 
polarization correlated with the state of the DCs induced by 
diff  erent pathogens. BM DCs treated with Proprionebacterium 
acnes induces Th1 cytokines, but, on the other hand, the same 
populations stimulated with soluble egg Ag activate a Th2-
type response (26, 27). Recently, a CD11clow population 
with immune regulatory properties was identifi  ed in the 
spleens of mice infected with Leishmania (28). Indeed, the 
CD8− DCs from malaria-infected spleens generated high 
levels of IL-10 production in the Tg T cells.
Our results suggest that populations of CD11c+ DCs have 
diff  erent but overlapping roles in malaria infection. Initial up-
take and presentation to T cells is performed by CD8+ DCs, 
which then undergo apoptosis as part of a normal regulatory 
mechanism, limiting a potentially damaging immune response. 
Although both DCs can induce the production of IFN-γ, 
CD8− DCs in the spleen could play a later role in Ag presenta-
tion and may support the Th2 and CD4 T cell–  mediated B cell 
helper response observed in this infection (1). The increase in 
the CD8− DC population in the spleen could also be important 
in the down-modulation of the immune response to malaria.
MATERIALS AND METHODS
Mice and parasites. Female BALB/c mice and B5 MSP-1–specifi  c TCR 
Tg mice (6–12 wk; reference 17) were bred in the specifi  c pathogen-free 
unit at the National Institute for Medical Research. P. chabaudi chabaudi (AS) 
infections were initiated by i.p. injection of 105 of parasitized RBCs and 
monitored as described previously (7). All mouse studies were performed in 
accordance with the United Kingdom Animals (Scientifi  c Procedures) Act 
of 1986. For the preparation of schizont-infected RBCs, blood was taken 
7 d after infection and purifi  ed as described previously (>90% schizont- or 
late trophozoite-stage infected RBCs; reference 7).
Cell lines and peptides. CD4+ T cell hybridomas B5 and B7, which are 
specifi  c for peptides of P. chabaudi MSP1, have been described previously 
(Fig. S1; reference 15).
Flow cytometry. The mAbs used were anti-CD8 FITC, CD8 PE, CD86 
PE, CD40 PE, CD11c APC, H-2Ad FITC, and isotype control Abs (BD 
Biosciences). Annexin V (BD Biosciences) and 7-AAD (1 μg/2.5 × 105 cells) 
were used to detect apoptotic cells.
Spleen cells from P. chabaudi–infected and naive mice were prepared, 
stained with Abs, and analyzed as described previously (18). Flow cytometry 
samples were acquired on a FACScalibur and analyzed with CellQuest soft-
ware (BD Biosciences).
DC enrichment and cell sorting. Spleens from naive or P. chabaudi–
  infected mice were treated for 30 min at 37°C with 0.4 mg/ml Liberase CI 
(Boehringer). After RBC lysis, spleen cells were enriched using CD11c mi-
crobeads (Miltenyi Biotec) and labeled with anti-CD11c APCs and -CD8 
FITC Abs (5) before sorting for viable CD11chigh DCs (>90% purity) on 
a MoFlo cytometer (DakoCytomation).
Ag presentation assays using B5 and B7 T cell hybridomas. Diff  er-
ent numbers of sorted DCs from mice at diff  erent times of infection were 
incubated with 2 × 104 B5 and B7 CD4 T cell hybridoma cells for 24 h 
in Iscove’s modifi  ed Dulbecco’s medium (Sigma-Aldrich), supernatants 
were added to CTLL-2 cells, and proliferation (as a measure of the IL-2 
produced) was determined (15). As positive controls, 1 μM of the respec-
tive peptide was added to the cultures. The IL-2 response of the hybrid-
omas refl   ected the amount of peptide presented after processing, and 
comparison with the maximum IL-2 response obtained when DCs are 
pulsed with a saturating dose of the synthetic peptide indicates the magni-
tude of the response.
Ag-specifi  c  proliferation. CD4+ splenic T cells were isolated (>95% 
  purity) from spleens of B5 Tg mice using anti-CD4 beads (Miltenyi Biotec). 
105 cells were then cultured with sorted DCs for 3 d in 200 μl in 96-well 
round-bottom plates and pulsed with 3H-thymidine (GE Healthcare) as 
  described previously (17).
Cytokine production. 5 × 104 sorted DCs were cultured in 200 μl in 
96-well round-bottom plates for 6 d with 105 CD4+ T cells purifi  ed from 
the spleens of Tg B5 mice as described previously (17). The cells were 
washed, and 105 cells were further cultured with 5 μg/ml of cross-linked 
anti-CD3 and 2 μg/ml anti-CD28 Ab in 250 μl in fl  at-bottomed 96-well 
plates as described previously (26). IL-2 was determined in the supernatant 
after 24 h, and IFN-γ, IL-4, and IL-10 was determined after 48 h of culture 
by ELISA as described previously (7).
Statistical analysis. Statistical analysis was performed using Student’s t tests 
for unpaired samples (two tailed). *, P = 0.05–0.01; **, P = 0.01–0.001; 
and ***, P < 0.001.
Online supplemental material. Fig. S1 shows the B5 and B7 T cell epit-
opes of MSP1 protein. Fig. S2 shows the expression of MHC class II and co-
stimulatory molecules CD86 and CD40 on CD11c+CD8+ and CD8− DCs 
during a primary infection with P. chabaudi. Fig. S3 shows that CD8+ DCs 
from uninfected mice presented MSP1 peptides more effi   ciently than CD8− 
DCs in vitro. Fig. S4 shows that both CD8+ and CD8− DCs from uninfected 
mice induced proliferation and cytokine production in malaria-specifi  c Tg 
T cells. Fig. S5 shows the location and increase in the numbers of CD11c+ DCs 
in the spleen of mice infected with P. chabaudi. Online supplemental material 
is available at http://www.jem.org/cgi/content/full/jem.20052450/DC1.
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